Research on ALS has increased dramatically in the last 30 years, [1] with a number of etiologic factors explored ( Table 1). Ninety percent to 95% of cases of ALS are sporadic (SALS), occurring ...
Long-term treatment with the cell therapy NurOwn (debamestrocel) was found to significantly extend survival in people with amyotrophic lateral sclerosis (ALS) when compared with a matched control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback